|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.26 USD | +0.38% |
|
+0.04% | -0.26% |
| 07-13 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| 07-10 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTELLAS PHARMA INC. | Other Pharmaceuticals | +0.38% | +0.04% | -0.26% | +36.23% | -22.98% | 23.69B |
-
|
-
|
-
|
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Charts Astellas Pharma Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
